COVID-19 Impact on Pharma: A Q1 Earnings Narrative

Aditya Kelkar

The COVID-19 outbreak generated widespread concern over how pharmaceutical, biotechnology, and medtech companies would cope with stringent national and regional lockdowns. Financial results from Q1 provide the first indicator of how this public health crisis will impact this industry and what the future may hold.  By early May, earnings for most of the significant players in the pharma industry had been announced, …

Selective Insights – Part 2

Heath Gross

Battling Bias The danger of Selective Insights is not limited to the government sector; it can prove costly in the business world as well. A few years ago, my firm was hired by a large software company to conduct research on a new money-management product their key competitor was rumored to be developing. The client was worried because they believed …

Anatomy of CI – Part 2

Heath Gross

Ad-hoc vs Monitoring Imagine if you tried to navigate a busy street but you could only see and hear for 5 seconds out of every minute.  Would that be a safe way to travel?  No, because the situation would change too fast, and with far too great of consequences to be safe.  Think about how most companies conduct competitive intelligence …

Anatomy of CI – Part 1

Heath Gross

Over the years there have been numerous comparisons between organizations and organisms, as they share many fundamental similarities, namely: Organisms are essentially ‘living’ systems that depend on the external environment to meet their needs Organizations are made up of interconnected sub systems that must work together to adapt, grow and thrive If you think of your organization as an organism, …